Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AMGN | VRTX | REGN | GILD |
| Company | Adaptimmune Ther ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.2000 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 1.2700 | 337.09 | 498.77 | 1,078.70 | 73.32 |
| Low | 1.1650 | 332.47 | 491.52 | 1,064.95 | 72.02 |
| Last | 1.2100 | 335.97 | 495.91 | 1,069.74 | 72.41 |
| Change | +0.0400 | +4.68 | +4.34 | +6.14 | -0.15 |
| % Change | +3.42% | +1.41% | +0.88% | +0.58% | -0.21% |
| Volume | 1,208,000 | 1,733,400 | 965,800 | 299,500 | 6,420,200 |
| 20-Day Average Volume | 1,708,070 | 2,088,675 | 1,139,580 | 425,975 | 6,556,275 |
| Previous Close | 1.1700 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1139 | 321.03 | 481.90 | 1,064.36 | 69.78 |
| 20-Day Raw Stochastic | 70.64% | 90.84% | 91.27% | 61.46% | 71.83% |
| 20-Day Relative Strength | 55.97% | 68.55% | 67.67% | 57.87% | 62.66% |
| Weighted Alpha | -12.07 | +42.09 | +44.33 | +42.33 | -4.80 |
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.81% since 07/15/24 | +1.76% since 07/15/24 | +1.03% since 07/15/24 | -1.14% since 07/15/24 | +2.26% since 07/15/24 |
| Low | 1.1300 on 07/19/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 1.3100 on 07/17/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +35.96% since 06/21/24 | +9.02% since 06/21/24 | +5.80% since 06/21/24 | +1.58% since 06/21/24 | +2.46% since 06/21/24 |
| Low | 0.8250 on 06/26/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 1.3700 on 07/15/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | +19.80% since 04/22/24 | +23.56% since 04/22/24 | +24.00% since 04/22/24 | +18.84% since 04/22/24 | +8.16% since 04/22/24 |
| Low | 0.8250 on 06/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.3700 on 07/15/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | +66.60% since 01/22/24 | +8.32% since 01/22/24 | +12.68% since 01/22/24 | +13.46% since 01/22/24 | -7.68% since 01/22/24 |
| Low | 0.6905 on 01/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 2.0500 on 03/08/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 288,785 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 246,825 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 60,280,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -113,870,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 5,680,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -48,500,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 2.31 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/15/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/14/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |